<DOC>
	<DOCNO>NCT01744587</DOCNO>
	<brief_summary>The purpose study investigate EBV reactivation rate post-radiation remission NPC patient , evaluate safety tolerance EGCG analyze observational correlation EBV reactivation clinical outcome .</brief_summary>
	<brief_title>Epstein-Barr Virus Reactivation Effect EGCG Virus Reactivation Remission Patients</brief_title>
	<detailed_description>Patients pathologically proven NPC , stage II-IVB finishing curative RT ≧70 Gy within 6 month ( ± induction/concurrent/adjuvant chemotherapy ) candidate study . Before entry , 8 CC venous blood obtain EBV DNA antibody screen test patient 's consent . Those undetectable plasma EBV DNA ( 0 copy/ml ) fulfil inclusion exclusion criterion register . Routine re-staging work-ups RT show active lesion nasopharynx , neck distant organ . Re-staging survey include nasopharyngoscope , pEBV DNA assay , CBC , platelet count , renal liver function test , CXR , abdominal sonography CT scan , whole body bone scan , MRI CT scan head neck region . Within one week finish registration , EGCG placebo start . A blood sample take EGCG/placebo collect antibody test pEBV DNA assay .</detailed_description>
	<mesh_term>Epigallocatechin gallate</mesh_term>
	<criteria>Histologically proven NPC . 2010 AJCC stage IIIVB . Age ≧ 20 year old . Performance status ECOG ≦ 2 . Finished RT ≧66 Gy within 6 month ( ± induction/concurrent/adjuvant chemotherapy ) . Clinical complete remission restaging workups within 3 month entry . Plasma EBV DNA = 0 copy/ml within 4 week entry . Adequate liver , renal , bone marrow function : Serum total bilirubin level ≦ 2.5 mg/dl . Serum creatinine ≦ 1.6 mg/dl . WBC ≧ 3,000/ul . Platelet count ≧ 100,000/ul . No intake EGCG similar dietary supplement . Signed informed consent . No anticancer treatment . Occurrence locoregional recurrence distant metastasis . Inadequate RT finish RT &gt; 6 month . Not complete remission restaging workups within 3 month entry . Plasma EBV DNA &gt; 0 copy/ml within 4 week entry . Intake EGCG similar dietary supplement recent 3 month . Severe cardiopulmonary disease ( unstable angina and/or congestive heart failure peripheral vascular disease require hospitalization within last 12 month ; chronic obstructive pulmonary disease exacerbation respiratory illness require hospitalization ) clinically significant psychiatric disorder .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>EBV</keyword>
	<keyword>EGCG</keyword>
</DOC>